These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 26997226)
1. Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay. Cunnion KM; Hair PS; Krishna NK; Whitley PH; Goldberg CL; Fadeyi EA; Maes LY Transfusion; 2016 Jul; 56(7):1845-8. PubMed ID: 26997226 [TBL] [Abstract][Full Text] [Related]
2. Discriminating the hemolytic risk of blood type A plasmas using the complement hemolysis using human erythrocytes (CHUHE) assay. Cunnion KM; Hair PS; Krishna NK; Sass MA; Enos CW; Whitley PH; Maes LY; Goldberg CL Transfusion; 2017 Mar; 57(3):517-524. PubMed ID: 28000304 [TBL] [Abstract][Full Text] [Related]
3. Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion. Weinstock C; Möhle R; Dorn C; Weisel K; Höchsmann B; Schrezenmeier H; Kanz L Transfusion; 2015 Mar; 55(3):605-10. PubMed ID: 25251967 [TBL] [Abstract][Full Text] [Related]
4. The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction. Roumenina LT; Bartolucci P; Pirenne F Transfus Med Rev; 2019 Oct; 33(4):225-230. PubMed ID: 31672341 [TBL] [Abstract][Full Text] [Related]
5. Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats. Kumar PS; Pallera HK; Hair PS; Rivera MG; Shah TA; Werner AL; Lattanzio FA; Cunnion KM; Krishna NK Transfusion; 2016 Aug; 56(8):2133-45. PubMed ID: 27282513 [TBL] [Abstract][Full Text] [Related]
6. Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution. Balbuena-Merle R; West FB; Tormey CA; Hendrickson JE Transfusion; 2019 Jun; 59(6):1911-1915. PubMed ID: 30865314 [TBL] [Abstract][Full Text] [Related]
7. Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease and the Role of the Classical Complement Pathway: A Case Report. Hair PS; Heck TP; Carr DT; Watson KD; Price J; Krishna NK; Cunnion KM; Owen WC J Hematol; 2021 Feb; 10(1):18-21. PubMed ID: 33643505 [TBL] [Abstract][Full Text] [Related]
8. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Gajewski JL; Petz LD; Calhoun L; O'Rourke S; Landaw EM; Lyddane NR; Hunt LA; Schiller GJ; Ho WG; Champlin RE Blood; 1992 Jun; 79(11):3076-85. PubMed ID: 1586749 [TBL] [Abstract][Full Text] [Related]
10. Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy. Yazdanbakhsh K; Kang S; Tamasauskas D; Sung D; Scaradavou A Blood; 2003 Jun; 101(12):5046-52. PubMed ID: 12576307 [TBL] [Abstract][Full Text] [Related]
11. Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients. Ibanez C; Habibi A; Mekontso-Dessap A; Chadebech P; Chami B; Bierling P; Galactéros F; Rieux C; Nataf J; Bartolucci P; Peyrard T; Pirenne F Transfusion; 2016 Jul; 56(7):1828-33. PubMed ID: 27145018 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and mechanisms of antibody-mediated hemolysis. Flegel WA Transfusion; 2015 Jul; 55 Suppl 2(0):S47-58. PubMed ID: 26174897 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of A plasma for incompatible patients. Olsen G; Passwater M; Huggins M; Mukhtar F; Pelletier P Transfusion; 2021 Feb; 61(2):375-378. PubMed ID: 33219552 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets. Mair B; Benson K Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394 [TBL] [Abstract][Full Text] [Related]
15. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Berséus O; Boman K; Nessen SC; Westerberg LA Transfusion; 2013 Jan; 53 Suppl 1():114S-123S. PubMed ID: 23301963 [TBL] [Abstract][Full Text] [Related]
16. Acute hemolysis of transfused A2 red cells by an auto-HI antibody. Darabi K; Makar RS Transfusion; 2008 May; 48(5):964-8. PubMed ID: 18454737 [TBL] [Abstract][Full Text] [Related]
17. Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions. Merle NS; Boudhabhay I; Leon J; Fremeaux-Bacchi V; Roumenina LT Transfus Clin Biol; 2019 May; 26(2):116-124. PubMed ID: 30879901 [TBL] [Abstract][Full Text] [Related]
18. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells. Irani MS; Karafin MS; Ernster L J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240 [TBL] [Abstract][Full Text] [Related]